Stockscreener 앱 받기
240.49
0.10%
-0.25
시간 외 거래:
240.49
전일 마감가:
$240.74
열려 있는:
$240.93
하루 거래량:
280.04K
Relative Volume:
0.56
시가총액:
$9.38B
수익:
$1.24B
순이익/손실:
$42.23M
주가수익비율:
226.88
EPS:
1.06
순현금흐름:
$150.33M
1주 성능:
-1.04%
1개월 성능:
-2.95%
6개월 성능:
-7.74%
1년 성능:
+41.98%
1일 변동 폭
$238.28
$243.27
1주일 범위
$234.34
$246.39
52주 변동 폭
$166.64
$310.00
Penumbra Inc Stock (PEN) Company Profile
명칭
Penumbra Inc
전화
(510) 995-2486
주소
ONE PENUMBRA PLACE, ALAMEDA, CA
PEN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PEN
Penumbra Inc
|
240.49 | 9.36B | 1.24B | 42.23M | 150.33M | 1.06 |
|
ABT
Abbott Laboratories
|
134.28 | 227.88B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.14 | 152.55B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
377.58 | 143.34B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.88 | 114.49B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.35 | 46.11B | 5.69B | 4.14B | 577.90M | 6.96 |
Penumbra Inc Stock (PEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-14 | 개시 | BofA Securities | Buy |
| 2025-01-21 | 개시 | UBS | Buy |
| 2024-12-17 | 개시 | Oppenheimer | Outperform |
| 2024-12-11 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-09-18 | 개시 | Stifel | Buy |
| 2024-09-03 | 개시 | Leerink Partners | Outperform |
| 2024-07-31 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-07-31 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-02-23 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2023-09-06 | 개시 | Morgan Stanley | Equal-Weight |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-03-29 | 다운그레이드 | Needham | Buy → Hold |
| 2023-01-30 | 개시 | Piper Sandler | Overweight |
| 2022-11-04 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-10-05 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-09-09 | 업그레이드 | Needham | Hold → Buy |
| 2022-07-18 | 개시 | RBC Capital Mkts | Outperform |
| 2022-04-19 | 개시 | Deutsche Bank | Buy |
| 2022-03-08 | 개시 | Needham | Hold |
| 2021-09-16 | 개시 | Truist | Buy |
| 2021-06-04 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2020-12-16 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2020-10-07 | 재개 | Canaccord Genuity | Buy |
| 2020-09-29 | 개시 | BTIG Research | Buy |
| 2020-09-08 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2019-06-13 | 재확인 | BofA/Merrill | Buy |
| 2019-05-30 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2019-05-21 | 개시 | William Blair | Outperform |
| 2018-10-29 | 재개 | BofA/Merrill | Buy |
| 2018-10-08 | 개시 | RBC Capital Mkts | Outperform |
| 2018-02-21 | 개시 | William Blair | Outperform |
| 2018-01-02 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2015-11-30 | 재확인 | Canaccord Genuity | Buy |
| 2015-10-13 | 개시 | Wells Fargo | Outperform |
모두보기
Penumbra Inc 주식(PEN)의 최신 뉴스
Penumbra Inc. Breaks Losing Streak — Is the Trend ReversingWeekly Chart Analysis With Entry Advice Provided - metal.it
Aspiration Thrombectomy Device Market Set to Witness - openPR.com
What makes Penumbra Inc. stock price move sharplyEarly Entry Picks Before News Breakout Reviewed - metal.it
Penumbra Inc.: Thrombectomy Business Expansion As a Significant Driver For Overall Market Share Growth! - Smartkarma
MACD Signals Flash Warning for Penumbra Inc. StockOptimized Watchlist With Daily Adjustments Launched - metal.it
How volatile is Penumbra Inc. stock compared to the marketAchieve breakthrough growth with proven strategies - Jammu Links News
Is it the right time to buy Penumbra Inc. stockBreakthrough profits - Jammu Links News
What are analysts’ price targets for Penumbra Inc. in the next 12 monthsRapid return acceleration - Jammu Links News
How strong is Penumbra Inc. company’s balance sheetFree Bull & Bear Market Updates - Jammu Links News
Is Penumbra Inc. a growth stock or a value stockAccelerated capital growth - Jammu Links News
Penumbra Inc. Stock Analysis and ForecastInvest smarter with real-time trading alerts - Jammu Links News
What are the latest earnings results for Penumbra Inc.Spectacular growth rates - Jammu Links News
What is the risk reward ratio of investing in Penumbra Inc. stockDiscover investment plans that deliver results - Jammu Links News
What are Penumbra Inc. company’s key revenue driversRapid portfolio appreciation - Jammu Links News
What institutional investors are buying Penumbra Inc. stockFree Risk Assessment Services - Jammu Links News
Results: Penumbra, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - simplywall.st
Penumbra, Inc. Reports Second Quarter 2025 Financial Results - ADVFN Brasil
Penumbra price target raised to $325 from $316 at Baird - TipRanks
Penumbra's Strong Growth Potential and Strategic Developments Support Buy Rating with $327 Price Target - AInvest
UBS Analyst Increases Penumbra's Price Target to $335 - AInvest
Penumbra to Present at Canaccord Genuity 45th Annual Growth Conference - AInvest
Penumbra, Inc. to Present at the Canaccord Genuity 45th Annual Growth Conference - Eastern Progress
Morgan Stanley Raises Price Target for Penumbra (PEN) to $266 | - GuruFocus
Should You Invest in Penumbra (PEN)? - Insider Monkey
Penumbra, Inc. (NYSE:PEN) Q2 2025 Earnings Call Transcript - Insider Monkey
Penumbra Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Penumbra outlines 13% to 15% revenue growth target for 2025 as thrombectomy adoption accelerates - MSN
Penumbra Inc. Reports Strong Q2 Earnings with Growth in U.S. Thrombectomy - TipRanks
Penumbra Surges 11.9% on Q2 Earnings Beat and Margin Expansion as $300M Volume Pushes It to 407th Trading Rank - AInvest
Penumbra (PEN) Q2 Revenue Jumps 13% - AOL.com
Penumbra (PEN) Shares Skyrocket, What You Need To Know - Yahoo Finance
Penumbra stock price target lowered to $325 at RBC Capital on margin outlook - Investing.com India
Penumbra: Truist Securities maintains a 'Buy' Rating, The Target Price is $310 - AInvest
Penumbra (PEN) Analyst Rating Update: Baird Raises Price Target - GuruFocus
Penumbra (PEN) Price Target Revised by RBC Capital | PEN Stock N - GuruFocus
Penumbra (PEN) Price Target Raised by Truist Following Earnings Beat - GuruFocus
Penumbra stock price target raised to $335 from $330 at UBS on solid growth - Investing.com
Penumbra (PEN) Price Target Raised by Baird to $285 - GuruFocus
Penumbra (PEN) Target Price Raised by Canaccord Genuity | PEN St - GuruFocus
Penumbra price target raised to $335 from $330 at UBS - TipRanks
Why Did Penumbra Stock Soar 14.46%? - AInvest
S&P 500 Futures Climb in Premarket Trading; Penumbra, Marvell Technology Lead - Barron's
Why Penumbra Inc. stock attracts strong analyst attentionScalable Portfolio Growth Suggestions Released - metal.it
Penumbra Inc (PEN) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Penumbra Inc (PEN) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
Penumbra Inc (PEN) Q2 2025 Earnings Call Highlights: Strong Reve - GuruFocus
Penumbra, Inc. Reports Strong Q2 2025 Results - TipRanks
Penumbra 2025 Q2 Earnings Strong Performance as Net Income Swings to Profit - AInvest
Penumbra's Q2 2025: Dissecting Contradictions on Thunderbolt FDA Review, Revenue Guidance, and Market Dynamics - AInvest
Penumbra Lifts Revenue Forecast As US Demand Climbs - Finimize
Penumbra Inc (PEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.17%
자본화:
|
볼륨(24시간):